Bo Franzén

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Machine Learning

Radical Prostatectomy

Prostate Cancer

Top Venues

Molecular oncology

Cytopathology : official journal of the British Society for Clinical Cytology

This page only lists publications with an associated author ORCID identifier.

Publications

Bo Franzén, Gert Auer, Rolf Lewensohn
Minimally invasive biopsy-based diagnostics in support of precision cancer medicine. Molecular oncology (2024)
Pontus Röbeck, Bo Franzén, Rafaele Cantera-Ahlman, Anca Dragomir, Gert Auer, Håkan Jorulf, Sven P Jacobsson, Kristina Viktorsson, Rolf Lewensohn, Michael Häggman, Sam Ladjevardi
Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade. Cytopathology : official journal of the British Society for Clinical Cytology (2023)
Pontus Röbeck, Bo Franzén, Rafaele Cantera-Ahlman, Anca Dragomir, Gert Auer, Håkan Jorulf, Sven P Jacobsson, Kristina Viktorsson, Rolf Lewensohn, Michael Häggman, Sam Ladjevardi
Multiplex protein analysis and ensemble machine learning methods of fine needle-aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumor grade. Cytopathology : official journal of the British Society for Clinical Cytology (2023)
Kristina Viktorsson, Petra Hååg, Carl-Henrik Shah, Bo Franzén, Vasiliki Arapi, Karin Holmsten, Per Sandström, Rolf Lewensohn, Anders Ullén
Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome. Molecular oncology 16 (20) (2022)
Bo Franzén, Kristina Viktorsson, Caroline Kamali, Eva Darai-Ramqvist, Vitali Grozman, Vasiliki Arapi, Petra Hååg, Vitaliy O Kaminskyy, Per Hydbring, Lena Kanter, Sven Nyrén, Simon Ekman, Luigi De Petris, Rolf Lewensohn
Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage. Molecular oncology 15 (11) (2021)